Preferred Label : (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol;

MeSH note : structure in first source;

CISMeF synonym : LX4211;

MeSH synonym : sotagliflozin;

MeSH hyponym : LX-4211;

Is substance : O;

UNII : 6B4ZBS263Y;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/zynquista
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
diabetes mellitus, type 1
adult
drug therapy, combination
insulin
administration, oral
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitors
Sodium-Glucose transporter 1
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sotagliflozin
glycosides
glycosides

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.